Physician
Family Medicine
Dr. Harrihar A. Pershadsingh, MD
|
|
Give Review
Harrihar A. Pershadsingh works in the field of Family Medicine. He graduated from University of Missouri-Columbia School of Medicine. Harrihar Pershadsingh is a published MD. He has 59 publications published. The most current publication "Treatment of psoriasis with troglitazone therapy."
Publications
- Relation of metabolic syndrome components to left ventricular mass in Mexican Americans versus non-Hispanic whites.
- Design, synthesis, and docking studies of novel benzimidazoles for the treatment of metabolic syndrome.
- Do differences in subclinical cardiovascular disease in mexican americans versus European americans help explain the Hispanic paradox?
- PPARgamma Agonists: Potential as Therapeutics for Neovascular Retinopathies.
- Design and synthesis of the first generation of dithiolane thiazolidinedione- and phenylacetic acid-based PPARgamma agonists.
- BP-1107 [{2-[4-(2,4-dioxo-thiazolidin-5-ylmethyl)-phenoxy]-ethyl}-methyl-amide]: a novel synthetic thiazolidinedione that inhibits epidermal hyperplasia in psoriatic s...
- Improvement in psoriasis with rosiglitazone in a diabetic and a nondiabetic patient.
- Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPARgamma-modulating activity.
- Effect of pioglitazone treatment in a patient with secondary multiple sclerosis.
- Insulin-sensitizing effects of telmisartan: implications for treating insulin-resistant hypertension and cardiovascular disease.
- Rosiglitazone inhibits proliferation, motility, and matrix metalloproteinase production in keratinocytes.
- Pharmacogenetic evidence that cd36 is a key determinant of the metabolic effects of pioglitazone.
- Peroxisome proliferator-activated receptor-gamma agonists prevent experimental autoimmune encephalomyelitis.
- A comparison of nisoldipine ER and amlodipine for the treatment of mild to moderate hypertension.
- Ligands for the peroxisome proliferator-activated receptor-gamma and the retinoid X receptor-alpha exert synergistic antiproliferative effects on human coronary artery...
- Troglitazone improves psoriasis and normalizes models of proliferative skin disease: ligands for peroxisome proliferator-activated receptor-gamma inhibit keratinocyte ...
- Peroxisome proliferator-activated receptor (PPAR)-gamma expression in human vascular smooth muscle cells: inhibition of growth, migration, and c-fos expression by the ...
- Treatment of psoriasis with troglitazone therapy.
- Effects of thiazolidinediones on growth and differentiation of human aorta and coronary myocytes.
- Effects of ciglitazone on blood pressure and intracellular calcium metabolism.
- Phosphate-dependent, trifluoperazine-sensitive Ca2+ efflux from rat liver mitochondria. Modulation by a cytosol factor.
- Ampicillin-resistant Listeria monocytogenes meningitis in a previously healthy 14-year-old athlete.
- Parallel stimulation in adipocytes of the plasma membrane Ca2+-transport/(Ca2+ + Mg2+)-ATPase system and mitochondrial pyruvate dehydrogenase by a supernatant factor d...
- Ca2+-activated ATPase and ATP-dependent calmodulin-stimulated Ca2+ transport in islet cell plasma membrane.
- Ca2+-dependent depolarization of energized mitochondrial membrane potential by chlortetracycline (aureomycin).
- Hormone-receptor coupling and the molecular mechanism of insulin action in the adipocyte: a paradigm for Ca2+ homeostasis in the initiation of the insulin-induced meta...
- A high-affinity, calmodulin-sensitive (Ca2+ + Mg2+)-ATPase and associated calcium-transport pump in the Ehrlich ascites tumor cell plasma membrane.
- The (Ca2+ +Mg2+)-ATPase of adipocyte plasma membrane: regulation by calmodulin and insulin.
- Calmodulin-sensitive ATP-dependent Ca2+ transport across adipocyte plasma membranes.
- A high affinity calcium-stimulated magnesium-dependent adenosine triphosphatase in rat adipocyte plasma membranes.
- Association of diltiazem therapy with increased insulin resistance in a patient with type I diabetes mellitus.
- The role of calcium and calmodulin in insulin receptor function in the adipocyte.
- Cellular mechanisms of insulin action: implications for insulin resistance and type II diabetes mellitus.
- False increases in serum creatine kinase MB isoenzyme detected in two patients by the Behring CK-MB quantitative immunometric assay.
- Chelation of intracellular calcium prevents stimulation of glucose transport by insulin and insulinomimetic agents in the adipocyte. Evidence for a common mechanism.
- Insulin-dependent alterations of phorbol ester binding to adipocyte subcellular constituents. Evidence for the involvement of protein kinase C in insulin action.
- Chelation of intracellular calcium blocks insulin action in the adipocyte.
- myo-Inositol 1,4,5-trisphosphate mobilizes Ca2+ from isolated adipocyte endoplasmic reticulum but not from plasma membranes.
- The Zucker fatty rat as a genetic model of obesity and hypertension.
- Flow cytometric analysis of mature adipocytes.
- Evidence for a sodium/calcium exchanger and voltage-dependent calcium channels in adipocytes.
- Palmitic acid stimulates glucose incorporation in the adipocyte by a mechanism likely involving intracellular calcium.
- A calmodulin dependent Ca2+-activated K+ channel in the adipocyte plasma membrane.
- Influence of Ca2+ on the plasma membrane potential and electrogenic uptake of glycine by myeloma cells. Involvement of a Ca2+-activated K+ channel.
- Comparison of DMO and flow cytometric methods for measuring intracellular pH and the effect of hyperthermia on the transmembrane pH gradient.
- The role of intracellular pH and its variance in low pH sensitization of killing by hyperthermia.
- Fluorescent tetradecanoylphorbol acetate: a novel probe of phorbol ester binding domains.
- Calcium channels in PDGF-stimulated A172 cells open after intracellular calcium release and are not voltage-dependent.
- Inhibition of glial cell proinflammatory activities by peroxisome proliferator-activated receptor gamma agonist confers partial protection during antimyelin oligodendr...
- Peroxisome proliferator-activated receptor-gamma: therapeutic target for diseases beyond diabetes: quo vadis?
- Alpha-Lipoic acid-based PPARgamma agonists for treating inflammatory skin diseases.
- Inhibition of corneal neovascularization by a peroxisome proliferator-activated receptor-gamma ligand.
- Dual Peroxisome Proliferator-Activated Receptor-alpha/gamma Agonists : In the Treatment of Type 2 Diabetes Mellitus and the Metabolic Syndrome.
- Treating the metabolic syndrome using angiotensin receptor antagonists that selectively modulate peroxisome proliferator-activated receptor-gamma.
- Type 2 diabetes and oral antihyperglycemic drugs.
- Alpha-lipoic acid: physiologic mechanisms and indications for the treatment of metabolic syndrome.
- Thiazolidinediones: potential as therapeutics for psoriasis and perhaps other hyperproliferative skin disease.
- Endothelial function and urine albumin levels among asymptomatic Mexican-Americans and non-Hispanic whites.
Schools
University Of MissouriColumbia School Of Medicine
Barnes Jewish Hospital
Kern Med Center
Doctors Specialties
- Family Medicine
Accepted Insurances
- Choice Plus POS II
Education
-
UCSF -
Barnes-Jewish Hospital -
Washington University - Barnes-Jewish Hospital -
University of Missouri-Columbia School of Medicine
Helpful Reviews
Similar Doctors
|
Dr. Cheng T. Yeh, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Srilakshmi Madhusudhan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Greti I. Petersen, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Tracey L. Levens, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Fidel B. Huerta, MD |
|
|
Dr. Harini Goli, MD |
|
|
Dr. Dyan Cole, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. William W. Weisman, OD |
|
|
Dr. Raghvendra P. Singh, DO |
|
|
Dr. Chandrakala B. Rudraraju, MD
This Doctor is OpenDoctor Recommended.
|